Literature DB >> 12829426

The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity.

Keith A Trujillo1.   

Abstract

Long-term administration of opiates leads to changes in the effects of these drugs, including tolerance, sensitization and physical dependence. There is, as yet, incomplete understanding of the neural mechanisms that underlie these phenomena. Tolerance, sensitization and physical dependence can be considered adaptive processes similar to other experience-dependent changes in the brain, such as learning and neural development. There is considerable evidence demonstrating that N-methyl-D-aspartate (NMDA) receptors and downstream signaling cascades may have an important role in different forms of experience-dependent changes in the brain and behavior. This review will explore evidence indicating that NMDA receptors and downstream messengers may be involved in opiate tolerance, sensitization and physical dependence. This evidence has been used to develop a cellular model of NMDA receptor/opiate interactions. According to this model, mu opioid receptor stimulation leads to a protein kinase C-mediated activation of NMDA receptors. Activation of NMDA receptors leads to influx of calcium and activation of calcium-dependent processes. These calcium-dependent processes have the ability to produce critical changes in opioid-responsive neurons, including inhibition of opioid receptor/second messenger coupling. This model is similar to cellular models of learning and neural development in which NMDA receptors have a central role. Together, the evidence suggests that the mechanisms that underlie changes in the brain and behavior produced by long-term opiate use may be similar to other central nervous system adaptations. The experimental findings and the resulting model may have implications for the treatment of pain and addiction.

Entities:  

Year:  2002        PMID: 12829426     DOI: 10.1080/10298420290023954

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  219 in total

1.  Rostrocaudal variation in targeting of N-methyl-D-aspartate and mu-opioid receptors in the rat medial nucleus of the solitary tract.

Authors:  J Huang; H Wang; V M Pickel
Journal:  J Comp Neurol       Date:  2000-06-05       Impact factor: 3.215

Review 2.  Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons.

Authors:  S M Crain; K F Shen
Journal:  Trends Pharmacol Sci       Date:  1990-02       Impact factor: 14.819

Review 3.  Glutamate receptors in the mammalian central nervous system.

Authors:  S Ozawa; H Kamiya; K Tsuzuki
Journal:  Prog Neurobiol       Date:  1998-04       Impact factor: 11.685

Review 4.  Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior.

Authors:  H N Bhargava
Journal:  Pharmacol Rev       Date:  1994-09       Impact factor: 25.468

Review 5.  Agonist induced constitutive receptor activation as a novel regulatory mechanism. Mu receptor regulation.

Authors:  W Sadée; Z Wang
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

6.  Involvement of phospholipid signal transduction pathways in morphine tolerance in mice.

Authors:  F L Smith; A B Lohmann; W L Dewey
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

7.  Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence.

Authors:  M Makimura; H Sugimoto; K Shinomiya; Y Kabasawa; H Fukuda
Journal:  J Toxicol Sci       Date:  1996-05       Impact factor: 2.196

8.  Modulation of Ca2+/calmodulin-dependent protein kinase II activity by acute and chronic morphine administration in rat hippocampus: differential regulation of alpha and beta isoforms.

Authors:  L Lou; T Zhou; P Wang; G Pei
Journal:  Mol Pharmacol       Date:  1999-03       Impact factor: 4.436

9.  Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor.

Authors:  Y A Kolesnikov; C G Pick; G Ciszewska; G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

10.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

View more
  25 in total

1.  Neurodevelopmental liabilities of substance abuse.

Authors:  Tomas Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

Review 2.  Contribution to variability in response to opioids.

Authors:  Geoffrey W Hanks; Colette Reid
Journal:  Support Care Cancer       Date:  2004-12-10       Impact factor: 3.603

3.  Behavioral sensitization to ethanol does not result in cross-sensitization to NMDA receptor antagonists.

Authors:  Paul J Meyer; Tamara J Phillips
Journal:  Psychopharmacology (Berl)       Date:  2007-07-26       Impact factor: 4.530

4.  The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control.

Authors:  María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Ana Vicente-Sánchez; Esther Berrocoso; Javier Garzón
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

5.  Differences between adolescents and adults in the acute effects of PCP and ketamine and in sensitization following intermittent administration.

Authors:  Angelica Rocha; Nigel Hart; Keith A Trujillo
Journal:  Pharmacol Biochem Behav       Date:  2017-04-22       Impact factor: 3.533

Review 6.  Ketamine: The final frontier or another depressing end?

Authors:  Omar K Sial; Eric M Parise; Lyonna F Parise; Tamara Gnecco; Carlos A Bolaños-Guzmán
Journal:  Behav Brain Res       Date:  2020-02-01       Impact factor: 3.332

7.  Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice.

Authors:  Camron D Bryant; Kristofer W Roberts; Janet S Byun; Michael S Fanselow; Christopher J Evans
Journal:  Pharmacol Biochem Behav       Date:  2006-12-28       Impact factor: 3.533

Review 8.  Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms.

Authors:  Joseph T Coyle
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

9.  NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats.

Authors:  Ian A Mendez; Keith A Trujillo
Journal:  Psychopharmacology (Berl)       Date:  2007-11-10       Impact factor: 4.530

10.  GRIN1 regulates micro-opioid receptor activities by tethering the receptor and G protein in the lipid raft.

Authors:  Xin Ge; Yu Qiu; Horace H Loh; Ping-Yee Law
Journal:  J Biol Chem       Date:  2009-10-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.